J 2021

SDHC Methylation Pattern in Patients With Carney Triad

DAUMOVA, Magdalena, Marian SVAJDLER, Pavel FABIAN, Leoš KŘEN, Iva BABANKOVA et. al.

Základní údaje

Originální název

SDHC Methylation Pattern in Patients With Carney Triad

Autoři

DAUMOVA, Magdalena (203 Česká republika), Marian SVAJDLER (203 Česká republika), Pavel FABIAN (203 Česká republika), Leoš KŘEN (203 Česká republika, domácí), Iva BABANKOVA (203 Česká republika), Marta JEŽOVÁ (203 Česká republika, domácí), Monika SEDIVCOVA (203 Česká republika), Tomas VANECEK (203 Česká republika), Kristyna BEHENSKA (203 Česká republika), Michal MICHAL (203 Česká republika) a Ondrej DAUM (203 Česká republika, garant)

Vydání

APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, PHILADELPHIA, LIPPINCOTT WILLIAMS & WILKINS, 2021, 1541-2016

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30109 Pathology

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 1.992

Kód RIV

RIV/00216224:14110/21:00124184

Organizační jednotka

Lékařská fakulta

UT WoS

000696558400009

Klíčová slova anglicky

Carney triad; somatic mosaicism; SDHC; methylation

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 16. 2. 2022 10:39, Mgr. Tereza Miškechová

Anotace

V originále

Carney triad is a multitumor syndrome affecting almost exclusively young women in a nonfamilial setting, which manifests by multifocal gastric gastrointestinal stromal tumors, paragangliomas, and pulmonary chondroma. The Carney triad-associated tumors are characterized by a deficiency of the mitochondrial succinate dehydrogenase enzymatic complex. Recently, it has been observed that the deficiency results from epigenetic silencing of the SDHC gene by its promoter hypermethylation. To elucidate anatomic distribution of SDHC promoter methylation in Carney triad patients and thus to shed some light on the possible natural development of this epigenetic change, both neoplastic and available non-neoplastic tissues of 3 patients with Carney triad were tested for hypermethylation at the SDHC promoter site. SDHC promoter hypermethylation was proven in all tumors studied. Lack of SDHC epigenetic silencing in the non-neoplastic lymphoid and duodenal tissue (ie, tissues not involved in the development of Carney triad-associated tumors) together with the finding of SDHC promoter hypermethylation in the non-neoplastic gastric wall favors the hypothesis of postzygotic somatic mosaicism as the biological background of Carney triad; it also offers an explanation of the multifocality of gastrointestinal stromal tumors of the stomach occurring in this scenario as well. However, the precise mechanism responsible for the peculiar organ-specific distribution of Carney triad-associated tumors is still unknown.